William Sharbaugh
Chief Operating Officer chez Jaguar Holding Company II
Profil
M. William J. Sharbaugh est directeur de l'exploitation chez PPD, Inc. et directeur de l'exploitation chez Pharmaceutical Product Development LLC, directeur de l'exploitation chez Eagle Holding Company II LLC et directeur de l'exploitation chez Jaguar Holding Company II. Il est membre du conseil d'administration de Wildcat Acquisition Holdings (UK) Ltd. Auparavant, M. Sharbaugh a été employé comme directeur de l'exploitation chez Pharmaceutical Product Development LLC, vice-président des opérations de développement mondial chez Bristol Myers Squibb Co. et directeur chez Merck & Co., Inc. Il a également été membre du conseil d'administration de Clinical Research Advantage, Inc. Il a obtenu son diplôme de premier cycle à l'Académie militaire américaine, un diplôme d'études supérieures à la Wharton School de l'Université de Pennsylvanie, un diplôme d'études supérieures à la Temple University School of Pharmacy et un diplôme d'études supérieures à l'Université de Boston.
Postes actifs de William Sharbaugh
| Sociétés | Poste | Début |
|---|---|---|
Jaguar Holding Company II
 Jaguar Holding Company II Medical SpecialtiesHealth Technology Jaguar Holding Co. II operates as a holding company. The company is headquartered in Wilmington, NC. | Chief Operating Officer | - |
Eagle Holding Company II LLC
 Eagle Holding Company II LLC Miscellaneous Commercial ServicesCommercial Services Eagle Holding Company II LLC operates as a holding company which engages in the provision of clinical development, post-approval, and laboratory services. The company is headquartered in Wilmington, NC. | Chief Operating Officer | - |
Wildcat Acquisition Holdings (UK) Ltd.
 Wildcat Acquisition Holdings (UK) Ltd. Financial ConglomeratesFinance Wildcat Acquisition Holdings (UK) Ltd. is an investment holding British company founded in 2011. The company is based in Cambridge, UK. | Director/Board Member | 05/12/2011 |
Anciens postes connus de William Sharbaugh
| Sociétés | Poste | Fin |
|---|---|---|
| PPD, INC. | Chief Operating Officer | 08/12/2021 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2007 |
Clinical Research Advantage, Inc.
 Clinical Research Advantage, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Research Advantage, Inc. provides research services to the pharmaceutical companies and clinical research organizations. The company was founded in 1992 and is headquartered in Tempe, AZ. | Director/Board Member | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Pharmaceutical Product Development LLC
 Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | Chief Operating Officer | - |
Formation de William Sharbaugh
| Boston University | Graduate Degree |
| US Military Academy | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Graduate Degree |
| Temple University School of Pharmacy | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
Clinical Research Advantage, Inc.
Clinical Research Advantage, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Research Advantage, Inc. provides research services to the pharmaceutical companies and clinical research organizations. The company was founded in 1992 and is headquartered in Tempe, AZ. | Commercial Services |
Jaguar Holding Company II
Jaguar Holding Company II Medical SpecialtiesHealth Technology Jaguar Holding Co. II operates as a holding company. The company is headquartered in Wilmington, NC. | Health Technology |
Eagle Holding Company II LLC
Eagle Holding Company II LLC Miscellaneous Commercial ServicesCommercial Services Eagle Holding Company II LLC operates as a holding company which engages in the provision of clinical development, post-approval, and laboratory services. The company is headquartered in Wilmington, NC. | Commercial Services |
PPD, Inc.
 PPD, Inc. Miscellaneous Commercial ServicesCommercial Services PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
Wildcat Acquisition Holdings (UK) Ltd.
Wildcat Acquisition Holdings (UK) Ltd. Financial ConglomeratesFinance Wildcat Acquisition Holdings (UK) Ltd. is an investment holding British company founded in 2011. The company is based in Cambridge, UK. | Finance |
